{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:22:53Z","timestamp":1785280973178,"version":"3.55.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2018YFC1311300"],"award-info":[{"award-number":["2018YFC1311300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regional Innovation and Development Joint Fund of National Natural Science Foundation of China","award":["U22A20269"],"award-info":[{"award-number":["U22A20269"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170245"],"award-info":[{"award-number":["82170245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370284"],"award-info":[{"award-number":["82370284"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370347"],"award-info":[{"award-number":["82370347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100256"],"award-info":[{"award-number":["82100256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042018kf1032"],"award-info":[{"award-number":["2042018kf1032"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>A novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptor agonist, tirzepatide (LY3298176, TZP), has been developed to treat Type 2 diabetes mellitus (T2DM). In ischaemic heart diseases, TZP is involved in cardiac metabolic processes. However, its efficacy and safety in treating heart failure (HF) following myocardial infarction (MI) remain uncertain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Herein, 12\u2005week C57BL\/6J mice were subjected to MI surgery, followed by administration of TZP. The effects of TZP on cardiac function and metabolism were thoroughly assessed by physiological, histological, and cellular analyses. Downstream effectors of TZP were screened through untargeted metabolomics analysis and molecular docking. Construct a lower branched chain amino acid (BCAA) diet model to determine whether TZP\u2019s cardioprotective effect is associated with reducing BCAA levels. Our results demonstrated that TZP reduced mortality following MI, decreased the infarct area, and attenuated cardiomyocyte necrosis. Pathological evaluation of cardiac tissues demonstrated increased fibrosis repair and decreased inflammatory infiltration. Mechanistically, untargeted metabolomics analysis uncovered a positive correlation between TZP and the BCAA catabolism pathway. The molecular docking verified that TZP could bind with branched-chain keto acid dehydrogenase E1 subunit \u03b1 (BCKDHA). TZP reduced BCKDHA phosphorylation at S293, enhanced BCAA catabolism, and inhibited the activation of metabolism by activating rapamycin (mTOR) signalling pathway. Furthermore, mice fed a low-BCAA diet post-MI demonstrated reduced cardiomyocyte necrosis, increased fibrosis repair, and decreased inflammatory infiltration. These cardioprotective effects were further enhanced when used synergistically with TZP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Taken together, our findings provide new perspectives on the unrecognized role of TZP in cardiac protection. TZP enhanced BCAA catabolism and attenuated BCAA\/mTOR signalling pathway in MI mice. Consequently, this study may present novel therapeutic options for patients with HF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cvr\/cvaf005","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T12:24:25Z","timestamp":1738239865000},"page":"454-467","source":"Crossref","is-referenced-by-count":12,"title":["Glucose-dependent insulinotropic polypeptide\/glucagon-like peptide 1 receptor agonist tirzepatide promotes branched chain amino acid catabolism to prevent myocardial infarction in non-diabetic mice"],"prefix":"10.1093","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3598-1243","authenticated-orcid":false,"given":"Mengya","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianxian","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-4226","authenticated-orcid":false,"given":"Wei","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University , Jiefang Road 238, Wuhan 430060 ,","place":["China"]},{"name":"Hubei Key Laboratory of Metabolic and Chronic Diseases , Wuhan 430060 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"2025042904114554800_cvaf005-B1","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1038\/s41467-023-39159-0","article-title":"Tisp40 prevents cardiac ischemia\/reperfusion injury through the hexosamine biosynthetic pathway in male mice","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"key":"2025042904114554800_cvaf005-B2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025042904114554800_cvaf005-B3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/cvr\/cvs109","article-title":"Novel therapeutic approaches to post-infarction remodelling","volume":"94","author":"Fraccarollo","year":"2012","journal-title":"Cardiovasc Res"},{"key":"2025042904114554800_cvaf005-B4","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.3390\/ijms22157831","article-title":"Targeting inflammation after myocardial infarction: a therapeutic opportunity for extracellular vesicles?","volume":"22","author":"Viola","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025042904114554800_cvaf005-B5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41574-022-00783-3","article-title":"Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP1","volume":"19","author":"Hammoud","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"2025042904114554800_cvaf005-B6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2025042904114554800_cvaf005-B7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/DMSO.S141235","article-title":"Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes","volume":"10","author":"Sikirica","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2025042904114554800_cvaf005-B8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metab"},{"key":"2025042904114554800_cvaf005-B9","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"key":"2025042904114554800_cvaf005-B10","doi-asserted-by":"crossref","first-page":"e146353","DOI":"10.1172\/JCI146353","article-title":"GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice","volume":"131","author":"Samms","year":"2021","journal-title":"J Clin Invest"},{"key":"2025042904114554800_cvaf005-B11","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.3390\/ijms21145013","article-title":"The regulatory role of T cell responses in cardiac remodeling following myocardial infarction","volume":"21","author":"Kino","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025042904114554800_cvaf005-B12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","article-title":"Metabolic remodelling in heart failure","volume":"15","author":"Bertero","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2025042904114554800_cvaf005-B13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12933-021-01419-y","article-title":"Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study","volume":"20","author":"Chevli","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2025042904114554800_cvaf005-B14","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/db18-0927","article-title":"Targeting BCAA catabolism to treat obesity-associated insulin resistance","volume":"68","author":"Zhou","year":"2019","journal-title":"Diabetes"},{"key":"2025042904114554800_cvaf005-B15","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"2025042904114554800_cvaf005-B16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/clinem\/dgab722","article-title":"Effects of tirzepatide, a dual GIP and GLP-1 RA, on lipid and metabolite profiles in subjects with type 2 diabetes","volume":"107","author":"Pirro","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2025042904114554800_cvaf005-B17","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/dom.14174","article-title":"The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes","volume":"22","author":"Wilson","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"2025042904114554800_cvaf005-B18","doi-asserted-by":"crossref","first-page":"101550","DOI":"10.1016\/j.molmet.2022.101550","article-title":"Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue","volume":"64","author":"Samms","year":"2022","journal-title":"Mol Metab"},{"key":"2025042904114554800_cvaf005-B19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41392-022-00971-7","article-title":"Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025042904114554800_cvaf005-B20","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3390\/cells11101706","article-title":"Exercise enhances branched-chain amino acid catabolism and decreases cardiac vulnerability to myocardial ischemic injury","volume":"11","author":"Wu","year":"2022","journal-title":"Cells"},{"key":"2025042904114554800_cvaf005-B21","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cvr\/cvab207","article-title":"Chronically elevated branched chain amino acid levels are pro-arrhythmic","volume":"118","author":"Portero","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2025042904114554800_cvaf005-B22","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.7150\/thno.44836","article-title":"Branched chain amino acids exacerbate myocardial ischemia\/reperfusion vulnerability via enhancing GCN2\/ATF6\/PPAR-\u03b1 pathway-dependent fatty acid oxidation","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"2025042904114554800_cvaf005-B23","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"key":"2025042904114554800_cvaf005-B24","doi-asserted-by":"crossref","first-page":"664457","DOI":"10.3389\/fimmu.2021.664457","article-title":"Cells of the immune system in cardiac remodeling: main players in resolution of inflammation and repair after myocardial infarction","volume":"12","author":"Kologrivova","year":"2021","journal-title":"Front Immunol"},{"key":"2025042904114554800_cvaf005-B25","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/cells11091386","article-title":"Properties and functions of fibroblasts and myofibroblasts in myocardial infarction","volume":"11","author":"Venugopal","year":"2022","journal-title":"Cells"},{"key":"2025042904114554800_cvaf005-B26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","article-title":"Myocardial remodeling after infarction: the role of myofibroblasts","volume":"7","author":"van den Borne","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"2025042904114554800_cvaf005-B27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1172\/JCI22304","article-title":"Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice","volume":"115","author":"Matsumura","year":"2005","journal-title":"J Clin Invest"},{"key":"2025042904114554800_cvaf005-B28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"2025042904114554800_cvaf005-B29","doi-asserted-by":"crossref","first-page":"H1160","DOI":"10.1152\/ajpheart.00114.2016","article-title":"Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction","volume":"311","author":"Wang","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025042904114554800_cvaf005-B30","doi-asserted-by":"crossref","first-page":"e169399","DOI":"10.1172\/JCI169399","article-title":"Reducing branched-chain amino acids improves cardiac stress response in mice by decreasing histone H3K23 propionylation","volume":"133","author":"Yang","year":"2023","journal-title":"J Clin Invest"},{"key":"2025042904114554800_cvaf005-B31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"2025042904114554800_cvaf005-B32","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2010.405","article-title":"Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes","volume":"303","author":"Phung","year":"2010","journal-title":"JAMA"},{"key":"2025042904114554800_cvaf005-B33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"2025042904114554800_cvaf005-B34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13300-020-00981-0","article-title":"The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials","volume":"12","author":"Min","year":"2021","journal-title":"Diabetes Ther"},{"key":"2025042904114554800_cvaf005-B35","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Seferovi\u0107","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2025042904114554800_cvaf005-B36","doi-asserted-by":"crossref","first-page":"e140532","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"key":"2025042904114554800_cvaf005-B37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.7326\/M15-1432","article-title":"Benefits and harms of once-weekly glucagon-like peptide-1 receptor agonist treatments: a systematic review and network meta-analysis","volume":"164","author":"Zaccardi","year":"2016","journal-title":"Ann Intern Med"},{"key":"2025042904114554800_cvaf005-B38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"2025042904114554800_cvaf005-B39","doi-asserted-by":"crossref","first-page":"1070973","DOI":"10.3389\/fphar.2023.1070973","article-title":"Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention","volume":"14","author":"Yin","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025042904114554800_cvaf005-B40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025042904114554800_cvaf005-B41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2025042904114554800_cvaf005-B42","doi-asserted-by":"crossref","first-page":"14999","DOI":"10.1038\/s41598-023-41819-6","article-title":"The amino acid metabolomics signature of differentiating myocardial infarction from strangulation death in mice models","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"2025042904114554800_cvaf005-B43","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1021\/acs.jproteome.9b00002","article-title":"Time series characteristics of serum branched-chain amino acids for early diagnosis of chronic heart failure","volume":"18","author":"Li","year":"2019","journal-title":"J Proteome Res"},{"key":"2025042904114554800_cvaf005-B44","doi-asserted-by":"crossref","first-page":"112704","DOI":"10.1016\/j.biopha.2022.112704","article-title":"Metabolomics analysis delineates the therapeutic effects of hydroethanolic extract of Cucumis sativus L. seeds on hypertension and isoproterenol-induced myocardial infarction","volume":"148","author":"Wahid","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"2025042904114554800_cvaf005-B45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","article-title":"Emerging roles for branched-chain amino acid metabolism in cancer","volume":"37","author":"Sivanand","year":"2020","journal-title":"Cancer Cell"},{"key":"2025042904114554800_cvaf005-B46","doi-asserted-by":"crossref","first-page":"e031617","DOI":"10.1161\/JAHA.123.031617","article-title":"Circulating branched chain amino acids and cardiometabolic disease","volume":"13","author":"Fine","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2025042904114554800_cvaf005-B47","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac energy metabolism in heart failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circ Res"},{"key":"2025042904114554800_cvaf005-B48","doi-asserted-by":"crossref","first-page":"115074","DOI":"10.1016\/j.bcp.2022.115074","article-title":"Amino acid metabolism, transport and signalling in the liver revisited","volume":"201","author":"Paulusma","year":"2022","journal-title":"Biochem Pharmacol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaf005\/61820943\/cvaf005.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/3\/454\/61820943\/cvaf005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/121\/3\/454\/61820943\/cvaf005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:12:05Z","timestamp":1745914325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/121\/3\/454\/8006610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,2,10]]},"published-print":{"date-parts":[[2025,4,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaf005","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,2]]}}}